Johnson & Johnson Portfolio Holdings

Johnson & Johnson

  • $427 Million
  • Q3 2025

Johnson & Johnson has filed its 13F form on November 13, 2025 for Q3 2025 where it was disclosed a total value porftolio of $427 Million distributed in 20 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Protagonist Therapeutics, Inc with a value of $163M, Nanobiotix S.A. with a value of $114M, Meira G Tx Holdings PLC with a value of $54.7M, Cv Rx, Inc. with a value of $32.1M, and Legend Biotech Corp with a value of $26.6M.

Examining the 13F form we can see an increase of $130M in the current position value, from $297M to 427M.

Johnson & Johnson is based out at New Brunswick, NJ

Below you can find more details about Johnson & Johnson portfolio as well as his latest detailed transactions.

Portfolio value $427 Million
Healthcare: $427 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$4.15B
$163 Million 38.07% of portfolio
2,449,183
Q3 2021 New
$713M
$114 Million 26.6% of portfolio
5,623,816
Q1 2024 Added 486.04%
$378M
$54.7 Million 12.79% of portfolio
6,641,064
Q4 2022 Added 129.12%
$187M
$32.1 Million 7.51% of portfolio
4,103,430
Q1 2024 Added 17.39%
$5.07B
$26.6 Million 6.21% of portfolio
814,586
Q2 2023 Reduced 50.0%
$1.32B
$12.8 Million 2.99% of portfolio
357,939
Q4 2022 Reduced 58.57%
$891M
$8.77 Million 2.05% of portfolio
748,062
Q4 2021 New
$4.37B
$8.54 Million 2.0% of portfolio
247,598
Q3 2022 Reduced 80.36%
$93.1M
$4.26 Million 1.0% of portfolio
3,379,064
Q3 2021 New
$20.6M
$2 Million 0.47% of portfolio
3,636,363
Q2 2024 New
$155M
$587,000 0.14% of portfolio
158,852
Q1 2024 Reduced 50.0%
$97.5M
$405,000 0.09% of portfolio
311,967
Q1 2024 New
$26.4M
$295,000 0.07% of portfolio
364,472
Q1 2024 Reduced 50.0%
$2.91B
$24,000 0.01% of portfolio
54,621
Q3 2021 New
$11.4M
$50,000 0.01% of portfolio
96,866
Q4 2024 Reduced 49.63%
Neumora Therapeutics, Inc.
-
$0 0.0% of portfolio
-
Q1 2024 Added 102.76%
Contineum Therapeutics Inc.
-
$0 0.0% of portfolio
-
Q2 2024 New
Rapport Therapeutics, Inc.
-
$0 0.0% of portfolio
-
Q3 2025 Reduced 28.56%
Vor Biopharma, Inc.
-
$0 0.0% of portfolio
-
Q3 2025 New

Summary

  • Portfolio
  • No. of Stocks 20
  • Current Value $427 Million
  • Prior Value $297 Million
  • Filing
  • Period Q3 2025
  • Filing Date November 13, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 2 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Johnson & Johnson Portfolio

Follow Johnson & Johnson and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson & Johnson, based on Form 13F filings with the SEC.

News

Stay updated on Johnson & Johnson with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email